Biomerica Historical Balance Sheet

BMRA Stock

USD 0.63 0.03 4.55%

Trend analysis of Biomerica balance sheet accounts such as Other Current Liab of 1.2 M, Total Current Liabilities of 1.3 M or Total Stockholder Equity of 14.2 M provides information on Biomerica's total assets, liabilities, and equity, which is the actual value of Biomerica to its prevalent stockholders. By breaking down trends over time using Biomerica balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Oil Shock

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Biomerica latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Biomerica is a good buy for the upcoming year.

Biomerica Inventory

2.21 Million

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.

About Biomerica Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Biomerica at a specified time, usually calculated after every quarter, six months, or one year. Biomerica Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Biomerica and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Biomerica currently owns. An asset can also be divided into two categories, current and non-current.

Biomerica Balance Sheet Chart

Biomerica Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Biomerica uses and utilizes its capital. It also shows what exactly a company owns and owes.

At present, Biomerica's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 1.2 M, whereas Total Current Liabilities is forecasted to decline to about 1.3 M.

Total Assets Other Current Liab Total Current Liabilities Short Term Investments Total Permanent Equity

Add Fundamental

Total Assets

Total assets refers to the total amount of Biomerica assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Biomerica books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Biomerica balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Biomerica are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Short Term Investments

Short Term Investments is an item under the current assets section of Biomerica balance sheet. It contains any investments Biomerica undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Biomerica can easily liquidate in the marketplace.

Most accounts from Biomerica's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Biomerica current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.At present, Biomerica's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Liabilities is expected to grow to about 1.2 M, whereas Total Current Liabilities is forecasted to decline to about 1.3 M.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	883.3K	1.2M	1.1M	1.2M
Total Assets	11.4M	14.5M	16.6M	17.5M

Other Current Liab Total Assets

Biomerica balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Accounts Payable	Short Long Term Debt Total	Short Term Debt	Intangible Assets	Common Stock Total Equity	Common Stock
Total Assets		0.66	0.74	0.99	0.89	-0.88	-0.78	0.94	0.67	0.23	0.94	0.01	0.8	0.77	0.48	0.4	0.89	0.79	0.89	1.0	0.24	-0.33	0.05	-0.11	0.61	0.85
Other Current Liab	0.66		0.74	0.62	0.42	-0.85	-0.63	0.83	0.11	-0.04	0.83	-0.62	0.53	0.39	-0.14	-0.17	0.7	0.58	0.74	0.7	-0.08	-0.17	0.56	0.37	0.22	0.61
Total Current Liabilities	0.74	0.74		0.68	0.69	-0.76	-0.8	0.75	0.47	0.3	0.75	-0.21	0.65	0.8	0.36	0.1	0.74	0.93	0.81	0.75	0.42	-0.15	0.19	-0.03	0.7	0.68
Total Stockholder Equity	0.99	0.62	0.68		0.87	-0.87	-0.75	0.94	0.66	0.18	0.94	0.03	0.78	0.72	0.46	0.44	0.87	0.74	0.86	0.99	0.19	-0.34	0.03	-0.12	0.57	0.83
Property Plant And Equipment Net	0.89	0.42	0.69	0.87		-0.64	-0.73	0.72	0.88	0.5	0.72	0.26	0.72	0.85	0.72	0.37	0.76	0.85	0.81	0.85	0.29	-0.33	-0.12	-0.25	0.72	0.71
Net Debt	-0.88	-0.85	-0.76	-0.87	-0.64		0.65	-0.97	-0.35	0.0	-0.97	0.36	-0.59	-0.55	-0.06	-0.31	-0.76	-0.71	-0.79	-0.91	-0.08	0.15	-0.38	-0.2	-0.38	-0.69
Retained Earnings	-0.78	-0.63	-0.8	-0.75	-0.73	0.65		-0.74	-0.56	-0.14	-0.74	0.12	-0.95	-0.67	-0.6	0.04	-0.95	-0.74	-0.93	-0.78	-0.16	0.52	0.23	0.44	-0.81	-0.94
Cash	0.94	0.83	0.75	0.94	0.72	-0.97	-0.74		0.43	0.05	1.0	-0.28	0.73	0.62	0.2	0.28	0.87	0.71	0.87	0.97	0.11	-0.27	0.27	0.09	0.45	0.81
Non Current Assets Total	0.67	0.11	0.47	0.66	0.88	-0.35	-0.56	0.43		0.47	0.43	0.44	0.54	0.69	0.79	0.32	0.53	0.7	0.59	0.59	0.17	-0.25	-0.33	-0.35	0.72	0.5
Non Currrent Assets Other	0.23	-0.04	0.3	0.18	0.5	0.0	-0.14	0.05	0.47		0.05	0.42	0.1	0.63	0.55	0.18	0.08	0.52	0.06	0.19	0.39	0.16	0.05	-0.02	0.39	0.06
Cash And Short Term Investments	0.94	0.83	0.75	0.94	0.72	-0.97	-0.74	1.0	0.43	0.05		-0.28	0.73	0.62	0.2	0.28	0.87	0.71	0.87	0.97	0.11	-0.27	0.27	0.09	0.45	0.81
Net Receivables	0.01	-0.62	-0.21	0.03	0.26	0.36	0.12	-0.28	0.44	0.42	-0.28		-0.04	0.34	0.57	0.46	-0.14	0.02	-0.2	-0.06	0.43	-0.08	-0.52	-0.4	0.17	-0.09
Common Stock Shares Outstanding	0.8	0.53	0.65	0.78	0.72	-0.59	-0.95	0.73	0.54	0.1	0.73	-0.04		0.63	0.64	0.0	0.97	0.6	0.91	0.79	0.16	-0.58	-0.32	-0.51	0.74	0.99
Non Current Liabilities Total	0.77	0.39	0.8	0.72	0.85	-0.55	-0.67	0.62	0.69	0.63	0.62	0.34	0.63		0.67	0.36	0.66	0.89	0.67	0.75	0.63	-0.13	-0.02	-0.19	0.72	0.62
Inventory	0.48	-0.14	0.36	0.46	0.72	-0.06	-0.6	0.2	0.79	0.55	0.2	0.57	0.64	0.67		0.23	0.52	0.53	0.47	0.42	0.39	-0.39	-0.65	-0.72	0.8	0.56
Other Current Assets	0.4	-0.17	0.1	0.44	0.37	-0.31	0.04	0.28	0.32	0.18	0.28	0.46	0.0	0.36	0.23		0.06	0.28	0.05	0.4	0.44	-0.01	-0.13	-0.13	0.14	0.05
Other Stockholder Equity	0.89	0.7	0.74	0.87	0.76	-0.76	-0.95	0.87	0.53	0.08	0.87	-0.14	0.97	0.66	0.52	0.06		0.68	0.96	0.89	0.14	-0.52	-0.12	-0.32	0.69	0.99
Total Liab	0.79	0.58	0.93	0.74	0.85	-0.71	-0.74	0.71	0.7	0.52	0.71	0.02	0.6	0.89	0.53	0.28	0.68		0.76	0.78	0.43	-0.11	0.1	-0.08	0.77	0.61
Property Plant And Equipment Gross	0.89	0.74	0.81	0.86	0.81	-0.79	-0.93	0.87	0.59	0.06	0.87	-0.2	0.91	0.67	0.47	0.05	0.96	0.76		0.89	0.13	-0.49	-0.04	-0.24	0.67	0.92
Total Current Assets	1.0	0.7	0.75	0.99	0.85	-0.91	-0.78	0.97	0.59	0.19	0.97	-0.06	0.79	0.75	0.42	0.4	0.89	0.78	0.89		0.24	-0.32	0.1	-0.07	0.58	0.85
Accounts Payable	0.24	-0.08	0.42	0.19	0.29	-0.08	-0.16	0.11	0.17	0.39	0.11	0.43	0.16	0.63	0.39	0.44	0.14	0.43	0.13	0.24		0.22	-0.04	-0.18	0.29	0.15
Short Long Term Debt Total	-0.33	-0.17	-0.15	-0.34	-0.33	0.15	0.52	-0.27	-0.25	0.16	-0.27	-0.08	-0.58	-0.13	-0.39	-0.01	-0.52	-0.11	-0.49	-0.32	0.22		0.54	0.55	-0.32	-0.55
Short Term Debt	0.05	0.56	0.19	0.03	-0.12	-0.38	0.23	0.27	-0.33	0.05	0.27	-0.52	-0.32	-0.02	-0.65	-0.13	-0.12	0.1	-0.04	0.1	-0.04	0.54		0.95	-0.45	-0.22
Intangible Assets	-0.11	0.37	-0.03	-0.12	-0.25	-0.2	0.44	0.09	-0.35	-0.02	0.09	-0.4	-0.51	-0.19	-0.72	-0.13	-0.32	-0.08	-0.24	-0.07	-0.18	0.55	0.95		-0.6	-0.42
Common Stock Total Equity	0.61	0.22	0.7	0.57	0.72	-0.38	-0.81	0.45	0.72	0.39	0.45	0.17	0.74	0.72	0.8	0.14	0.69	0.77	0.67	0.58	0.29	-0.32	-0.45	-0.6		0.7
Common Stock	0.85	0.61	0.68	0.83	0.71	-0.69	-0.94	0.81	0.5	0.06	0.81	-0.09	0.99	0.62	0.56	0.05	0.99	0.61	0.92	0.85	0.15	-0.55	-0.22	-0.42	0.7

Click cells to compare fundamentals

Biomerica Account Relationship Matchups

Biomerica balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	17.3M	11.8M	11.4M	14.5M	16.6M	17.5M
Other Current Liab	278.6K	540.7K	883.3K	1.2M	1.1M	1.2M
Total Current Liabilities	1.5M	1.3M	2.0M	1.9M	1.8M	1.3M
Total Stockholder Equity	14.2M	9.2M	8.3M	11.7M	13.5M	14.2M
Property Plant And Equipment Net	2.0M	1.9M	1.5M	1.2M	1.4M	1.5M
Net Debt	(6.9M)	(2.6M)	(4.5M)	(8.6M)	(7.8M)	(7.4M)
Retained Earnings	(21.9M)	(28.4M)	(35.1M)	(42.2M)	(38.0M)	(36.1M)
Cash	8.6M	4.2M	5.9M	9.7M	11.2M	11.7M
Non Current Assets Total	2.5M	2.6M	1.9M	1.7M	1.9M	1.3M
Non Currrent Assets Other	168.2K	264.2K	95.6K	79K	71.1K	67.5K
Cash And Short Term Investments	8.6M	4.2M	5.9M	9.7M	11.2M	11.7M
Net Receivables	1.8M	1.5M	773.8K	722K	649.8K	955.2K
Common Stock Shares Outstanding	10.2M	11.9M	12.7M	14.2M	16.3M	17.1M
Liabilities And Stockholders Equity	17.3M	11.8M	11.4M	14.5M	16.6M	17.5M
Non Current Liabilities Total	1.6M	1.3M	1.0M	785K	902.8K	857.6K
Inventory	2.9M	3.2M	2.4M	2.1M	2.4M	2.2M
Other Current Assets	1.5M	255.0	447.0	300K	270K	273.8K
Other Stockholder Equity	35.2M	36.7M	42.4M	52.7M	60.6M	63.6M
Total Liab	3.0M	2.6M	3.0M	2.7M	2.5M	1.4M
Property Plant And Equipment Gross	2.0M	1.9M	3.5M	3.2M	3.7M	3.9M
Total Current Assets	14.8M	9.2M	9.4M	12.8M	14.7M	15.5M
Accumulated Other Comprehensive Income	(39.8K)	(48.0K)	(73.9K)	(110K)	(126.5K)	(132.8K)
Accounts Payable	986.7K	431.6K	736K	344K	309.6K	575.0K
Intangible Assets	168.7K	294.8K	170K	165K	148.5K	276.5K
Common Stock Total Equity	711.0K	774.2K	939.2K	984.6K	1.1M	622.7K
Common Stock	939.2K	984.6K	1.0M	1.3M	1.5M	1.6M
Other Assets	168.2K	264.2K	363.0	79K	90.9K	86.3K
Property Plant Equipment	2.0M	1.9M	1.5M	1.2M	1.4M	1.5M
Net Tangible Assets	14.0M	8.9M	8.2M	11.6M	13.3M	7.8M
Net Invested Capital	14.2M	9.2M	8.3M	11.7M	13.5M	8.8M
Net Working Capital	13.3M	7.9M	7.4M	10.9M	12.5M	7.9M
Capital Stock	964.9K	984.6K	1.0M	1.3M	1.5M	1.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

GOOG	Alphabet Inc Class C
BAC	Bank of America
DD	Dupont De Nemours

When determining whether Biomerica offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Biomerica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biomerica Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biomerica Stock:

How To Invest In Biomerica

Details

Is Biomerica Stock a good investment?

Details

What is Biomerica's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.

You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Complementary Tools for Biomerica Stock analysis

When running Biomerica's price analysis, check to measure Biomerica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomerica is operating at the current time. Most of Biomerica's value examination focuses on studying past and present price action to predict the probability of Biomerica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomerica's price. Additionally, you may evaluate how the addition of Biomerica to your portfolios can decrease your overall portfolio volatility.

	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Transaction History View history of all your transactions and understand their impact on performance
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.

Is Biomerica's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. If investors know Biomerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.37)

Revenue Per Share

0.323

Quarterly Revenue Growth

(0.09)

Return On Assets

(0.43)

Return On Equity

(0.92)

The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomerica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biomerica Historical Balance Sheet

Biomerica Inventory

2.21 Million

About Biomerica Balance Sheet Analysis

Biomerica Balance Sheet Chart

Total Assets

Total Current Liabilities

Short Term Investments

Biomerica balance sheet Correlations

Biomerica Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biomerica balance sheet Accounts

Also Currently Popular

Complementary Tools for Biomerica Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Stockholder Equity	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Stockholder Equity
Common Stock	+ 0.99	Common Stock Shares Outstanding
Common Stock	+ 0.99	Other Stockholder Equity

Cash And Short Term Investments	- 0.97	Net Debt
Cash	- 0.97	Net Debt
Other Stockholder Equity	- 0.95	Retained Earnings
Common Stock Shares Outstanding	- 0.95	Retained Earnings
Common Stock	- 0.94	Retained Earnings
Property Plant And Equipment Gross	- 0.93	Retained Earnings